aTyr Pharma (LIFE) Revenue & Revenue Breakdown
aTyr Pharma Revenue Highlights
Latest Revenue (Y)
$353.00K
Latest Revenue (Q)
$235.00K
Main Segment (Y)
Collaboration Revenue
aTyr Pharma Revenue by Period
aTyr Pharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $353.00K | -96.60% |
2022-12-31 | $10.39M | 100.00% |
2021-12-31 | - | -100.00% |
2020-12-31 | $10.46M | 2377.49% |
2019-12-31 | $422.00K | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | - |
aTyr Pharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $235.00K | -94.55% |
2023-12-31 | $4.32M | 1122.38% |
2023-09-30 | $353.00K | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $10.39M | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | -100.00% |
2020-12-31 | $2.05M | 1287.16% |
2020-09-30 | $148.00K | -21.69% |
2020-06-30 | $189.00K | -97.66% |
2020-03-31 | $8.06M | 5500.69% |
2019-12-31 | $144.00K | -21.74% |
2019-09-30 | $184.00K | 95.74% |
2019-06-30 | $94.00K | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | - |
aTyr Pharma Revenue Breakdown
aTyr Pharma Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 22 | Dec 20 | Dec 19 |
---|---|---|---|
Collaboration Revenue | $10.00M | $422.00K | - |
License Revenue | - | $10.46M | - |
Latest
Quarterly Revenue by Product
Product/Service | Mar 24 | Sep 23 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|---|---|---|---|---|---|
Collaboration Revenue | $200.00K | $400.00K | $144.00K | $184.00K | $94.00K | - | - | - | - |
License Revenue | - | - | $2.05M | $148.00K | $189.00K | $8.06M | - | - | - |
Latest
aTyr Pharma Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|---|---|---|---|
License Revenue | $2.05M | $148.00K | $189.00K | $8.06M | - | - | - |
Collaboration Revenue | - | - | - | - | $144.00K | $184.00K | $94.00K |
Latest
aTyr Pharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AMLX | Amylyx Pharmaceuticals | $380.79M | $416.00K |
HOOK | HOOKIPA Pharma | $20.13M | - |
MREO | Mereo BioPharma Group | $10.00M | - |
LIFE | aTyr Pharma | $353.00K | $235.00K |
XFOR | X4 Pharmaceuticals | - | $560.00K |
PDSB | PDS Bio | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
TERN | Terns Pharmaceuticals | - | - |